Translation factors and ribosomal proteins control tumor onset and progression: how? (original) (raw)

• Kressler D, Hurt E, Bassler J . Driving ribosome assembly. Biochim Biophys Acta 2010; 1803: 673–683.
  CAS PubMed Google Scholar
• Crocker J, Skilbeck N . Nucleolar organiser region associated proteins in cutaneous melanotic lesions: a quantitative study. J Clin Pathol 1987; 40: 885–889.
  CAS PubMed PubMed Central Google Scholar
• Montanaro L, Trere D, Derenzini M . Nucleolus, ribosomes, and cancer. A J Pathol 2008; 173: 301–310.
  CAS Google Scholar
• Narla A, Ebert BL . Ribosomopathies: human disorders of ribosome dysfunction. Blood 2010; 115: 3196–3205.
  CAS PubMed PubMed Central Google Scholar
• De Keersmaecker K, Atak ZK, Li N, Vicente C, Patchett S, Girardi T et al. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia. Nat Genet 2013; 45: 186–190.
  CAS PubMed Google Scholar
• Iborra FJ, Jackson DA, Cook PR . Coupled transcription and translation within nuclei of mammalian cells. Science 2001; 293: 1139–1142.
  CAS PubMed Google Scholar
• Blagden SP, Willis AE . The biological and therapeutic relevance of mRNA translation in cancer. Nat Rev Clin Oncol 2011; 8: 280–291.
  Article CAS PubMed Google Scholar
• Fasolo A, Sessa C . Targeting mTOR pathways in human malignancies. Curr Pharm Des 2012; 18: 2766–2777.
  CAS PubMed Google Scholar
• Ruggero D . Translational control in cancer etiology. Cold Spring Harb Perspect Biol 2012; 5: a012336.
  Google Scholar
• Ramirez-Fort MK, Case EC, Rosen AC, Cerci FB, Wu S, Lacouture ME . Rash to the mTOR inhibitor everolimus: systematic review and meta-analysis. Am J Clin Oncol (doi:10.1097/COC.0b013e318277d62f).
  CAS PubMed Google Scholar
• Iorio MV, Croce CM . MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 2012; 4: 143–159.
  CAS PubMed PubMed Central Google Scholar
• Spizzo R, Almeida MI, Colombatti A, Calin GA . Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene 2012; 31: 4577–4587.
  CAS PubMed PubMed Central Google Scholar
• Pradet-Balade B, Boulme F, Beug H, Mullner EW, Garcia-Sanz JA . Translation control: bridging the gap between genomics and proteomics? Trends Biochem Sci 2001; 26: 225–229.
  CAS PubMed Google Scholar
• Schwanhausser B, Busse D, Li N, Dittmar G, Schuchhardt J, Wolf J et al. Global quantification of mammalian gene expression control. Nature 2012; 473: 337–342.
  Google Scholar
• Silvera D, Formenti SC, Schneider RJ . Translational control in cancer. Nat Rev Cancer 2011; 10: 254–266.
  Google Scholar
• Sonenberg N, Hinnebusch AG . Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell 2009; 136: 731–745.
  CAS PubMed PubMed Central Google Scholar
• Stumpf CR, Ruggero D . The cancerous translation apparatus. Curr Opin Genet Dev 2011; 21: 474–483.
  CAS PubMed PubMed Central Google Scholar
• Montanaro L, Trere D, Derenzini M . Changes in ribosome biogenesis may induce cancer by down-regulating the cell tumor suppressor potential. Biochim Biophys Acta 2012; 1825: 101–110.
  CAS PubMed Google Scholar
• Jackson RJ, Hellen CU, Pestova TV . The mechanism of eukaryotic translation initiation and principles of its regulation. Nat Rev Mol Cell Biol 2010; 11: 113–127.
  CAS PubMed PubMed Central Google Scholar
• Ben-Shem A, Garreau de Loubresse N, Melnikov S, Jenner L, Yusupova G, Yusupov M . The structure of the eukaryotic ribosome at 3.0 A resolution. Science 2012; 334: 1524–1529.
  Google Scholar
• Petrov A, Chen J, O'Leary S, Tsai A, Puglisi JD . Single-molecule analysis of translational dynamics. Cold Spring Harb Perspect Biol 2012; 4: a011551.
  PubMed PubMed Central Google Scholar
• Schoenberg DR, Maquat LE . Regulation of cytoplasmic mRNA decay. Nat Rev Genet 2012; 13: 246–259.
  CAS PubMed PubMed Central Google Scholar
• Filipowicz W, Bhattacharyya SN, Sonenberg N . Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 2008; 9: 102–114.
  CAS PubMed Google Scholar
• Kervestin S, Jacobson A . NMD: a multifaceted response to premature translational termination. Nat Rev Mol Cell Biol 2012; 13: 700–712.
  CAS PubMed PubMed Central Google Scholar
• Huntzinger E, Izaurralde E . Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genetics 2011; 12: 99–110.
  CAS PubMed Google Scholar
• Wu X, Chesoni S, Rondeau G, Tempesta C, Patel R, Charles S et al. Combinatorial mRNA binding by AUF1 and Argonaute 2 controls decay of selected target mRNAs. Nucleic Acids Res 2013; 41: 2644–2658.
  CAS PubMed PubMed Central Google Scholar
• Wang D, Zavadil J, Martin L, Parisi F, Friedman E, Levy D et al. Inhibition of nonsense-mediated RNA decay by the tumor microenvironment promotes tumorigenesis. Mol Cell Biol 2011; 31: 3670–3680.
  CAS PubMed PubMed Central Google Scholar
• Pichon X, Wilson LA, Stoneley M, Bastide A, King HA, Somers J et al. RNA binding protein/RNA element interactions and the control of translation. Cur Protein Pep Sci 2012; 13: 294–304.
  CAS Google Scholar
• Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, Schinzel AC et al. Initial genome sequencing and analysis of multiple myeloma. Nature 2011; 471: 467–472.
  CAS PubMed PubMed Central Google Scholar
• Pelletier J, Sonenberg N . Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 1988; 334: 320–325.
  CAS PubMed Google Scholar
• Balvay L, Soto Rifo R, Ricci EP, Decimo D, Ohlmann T . Structural and functional diversity of viral IRESes. Biochim Biophys Acta 2009; 1789: 542–557.
  CAS PubMed Google Scholar
• Spriggs KA, Stoneley M, Bushell M, Willis AE . Re-programming of translation following cell stress allows IRES-mediated translation to predominate. Biol Cell 2008; 100: 27–38.
  CAS PubMed Google Scholar
• Graber TE, Holcik M . Cap-independent regulation of gene expression in apoptosis. Mol Biosyst 2007; 3: 825–834.
  CAS PubMed Google Scholar
• Komar AA, Hatzoglou M . Cellular IRES-mediated translation: the war of ITAFs in pathophysiological states. Cell Cycle 2011; 10: 229–240.
  CAS PubMed PubMed Central Google Scholar
• Silvera D, Arju R, Darvishian F, Levine PH, Zolfaghari L, Goldberg J et al. Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer. Nat Cell Biol 2009; 11: 903–908.
  CAS PubMed Google Scholar
• Silvera D, Schneider RJ . Inflammatory breast cancer cells are constitutively adapted to hypoxia. Cell Cycle 2009; 8: 3091–3096.
  Article CAS PubMed Google Scholar
• Coldwell MJ, Mitchell SA, Stoneley M, MacFarlane M, Willis AE . Initiation of Apaf-1 translation by internal ribosome entry. Oncogene 2000; 19: 899–905.
  CAS PubMed Google Scholar
• Holcik M, Yeh C, Korneluk RG, Chow T . Translational upregulation of X-linked inhibitor of apoptosis (XIAP) increases resistance to radiation induced cell death. Oncogene 2000; 19: 4174–4177.
  CAS PubMed Google Scholar
• Yoon A, Peng G, Brandenburger Y, Zollo O, Xu W, Rego E et al. Impaired control of IRES-mediated translation in X-linked dyskeratosis congenita. Science 2006; 312: 902–906.
  CAS PubMed Google Scholar
• Barna M, Pusic A, Zollo O, Costa M, Kondrashov N, Rego E et al. Suppression of Myc oncogenic activity by ribosomal protein haploinsufficiency. Nature 2008; 456: 971–975.
  CAS PubMed PubMed Central Google Scholar
• Blau L, Knirsh R, Ben-Dror I, Oren S, Kuphal S, Hau P et al. Aberrant expression of c-Jun in glioblastoma by internal ribosome entry site (IRES)-mediated translational activation. Proc Natl Acad Sci USA 2012; 109: E2875–E2884.
  CAS PubMed PubMed Central Google Scholar
• Cobbold LC, Wilson LA, Sawicka K, King HA, Kondrashov AV, Spriggs KA et al. Upregulated c-myc expression in multiple myeloma by internal ribosome entry results from increased interactions with and expression of PTB-1 and YB-1. Oncogene 2010; 29: 2884–2891.
  CAS PubMed Google Scholar
• Jopling CL, Spriggs KA, Mitchell SA, Stoneley M, Willis AE . L-Myc protein synthesis is initiated by internal ribosome entry. RNA 2004; 10: 287–298.
  CAS PubMed PubMed Central Google Scholar
• Bellodi C, Kopmar N, Ruggero D . Deregulation of oncogene-induced senescence and p53 translational control in X-linked dyskeratosis congenita. EMBO J 2010; 29: 1865–1876.
  CAS PubMed PubMed Central Google Scholar
• Bellodi C, Krasnykh O, Haynes N, Theodoropoulou M, Peng G, Montanaro L et al. Loss of function of the tumor suppressor DKC1 perturbs p27 translation control and contributes to pituitary tumorigenesis. Cancer Res 2010; 70: 6026–6035.
  CAS PubMed PubMed Central Google Scholar
• Lewis SM, Holcik M . IRES in distress: translational regulation of the inhibitor of apoptosis proteins XIAP and HIAP2 during cell stress. Cell Death Differ 2005; 12: 547–553.
  CAS PubMed Google Scholar
• Willimott S, Wagner SD . Post-transcriptional and post-translational regulation of Bcl2. Biochem Soc Trans 2010; 38: 1571–1575.
  CAS PubMed Google Scholar
• Komar AA, Mazumder B, Merrick WC . A new framework for understanding IRES-mediated translation. Gene 2012; 502: 75–86.
  CAS PubMed PubMed Central Google Scholar
• Baird TD, Wek RC . Eukaryotic initiation factor 2 phosphorylation and translational control in metabolism. Adv Nutr 2012; 3: 307–321.
  CAS PubMed PubMed Central Google Scholar
• Hetz C . The unfolded protein response: controlling cell fate decisions under ER stress and beyond. Nat Rev Mol Cell Biol 2012; 13: 89–102.
  CAS PubMed Google Scholar
• Proud CG . eIF2 and the control of cell physiology. Semin Cell Dev Biol 2005; 16: 3–12.
  CAS PubMed Google Scholar
• Tabas I, Ron D . Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stress. Nat Cell Biol 2011; 13: 184–190.
  CAS PubMed PubMed Central Google Scholar
• Mujtaba T, Dou QP . Advances in the understanding of mechanisms and therapeutic use of bortezomib. Discov Med 2012; 12: 471–480.
  Google Scholar
• Dong H, Chen L, Chen X, Gu H, Gao G, Gao Y et al. Dysregulation of unfolded protein response partially underlies proapoptotic activity of bortezomib in multiple myeloma cells. Leuk Lymphoma 2009; 50: 974–984.
  CAS PubMed Google Scholar
• Obeng EA, Carlson LM, Gutman DM, Harrington WJ Jr, Lee KP, Boise LH . Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood 2006; 107: 4907–4916.
  CAS PubMed PubMed Central Google Scholar
• Suh DH, Kim MK, Kim HS, Chung HH, Song YS . Unfolded protein response to autophagy as a promising druggable target for anticancer therapy. Ann N Y Acad Sci 2012; 1271: 20–32.
  CAS PubMed PubMed Central Google Scholar
• Ingolia NT, Lareau LF, Weissman JS . Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell 2012; 147: 789–802.
  Google Scholar
• Ingolia NT, Ghaemmaghami S, Newman JR, Weissman JS . Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science 2009; 324: 218–223.
  CAS PubMed PubMed Central Google Scholar
• Fabian MR, Sonenberg N, Filipowicz W . Regulation of mRNA translation and stability by microRNAs. Annu Rev Biochem 2010; 79: 351–379.
  CAS PubMed Google Scholar
• Fabian MR, Sonenberg N . The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat Struct Mol Biol 2012; 19: 586–593.
  CAS PubMed Google Scholar
• Xu M, Mo YY . The Akt-associated microRNAs. Cell Mol Life Sci 2012; 69: 3601–3612.
  CAS PubMed PubMed Central Google Scholar
• Nana-Sinkam SP, Croce CM . Clinical applications for microRNAs in cancer. Clin Pharmacol Ther 2013; 93: 98–104.
  CAS PubMed Google Scholar
• Gutschner T, Diederichs S . The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol 2012; 9: 703–719.
  CAS PubMed PubMed Central Google Scholar
• Carrieri C, Cimatti L, Biagioli M, Beugnet A, Zucchelli S, Fedele S et al. Long non-coding antisense RNA controls Uchl1 translation through an embedded SINEB2 repeat. Nature 2012; 491: 454–457.
  CAS PubMed Google Scholar
• Shaw RJ, Cantley LC . Ras, PI(3)K and mTOR signaling controls tumor cell growth. Nature 2006; 441: 424–430.
  CAS PubMed Google Scholar
• Proud CG . Signaling to translation: how signal transduction pathways control the protein synthetic machinery. Biochem J 2007; 403: 217–234.
  CAS PubMed Google Scholar
• Proud CG . Regulation of protein synthesis by insulin. Biochem Soc Trans 2006; 34: 213–216.
  CAS PubMed Google Scholar
• Wang X, Proud CG . A novel mechanism for the control of translation initiation by amino acids, mediated by phosphorylation of eukaryotic initiation factor 2B. Mol Cell Biol 2008; 28: 1429–1442.
  CAS PubMed Google Scholar
• Gallagher JW, Kubica N, Kimball SR, Jefferson LS . Reduced eukaryotic initiation factor 2Bepsilon-subunit expression suppresses the transformed phenotype of cells overexpressing the protein. Cancer Res 2008; 68: 8752–8760.
  CAS PubMed PubMed Central Google Scholar
• Dalton LE, Healey E, Irving J, Marciniak SJ . Phosphoproteins in stress-induced disease. Prog Mol Biol Transl Sci 2012; 106: 189–221.
  CAS PubMed Google Scholar
• Walter P, Ron D . The unfolded protein response: from stress pathway to homeostatic regulation. Science 2011; 334: 1081–1086.
  CAS PubMed Google Scholar
• Gallinetti J, Harputlugil E, Mitchell JR . Amino acid sensing in dietary-restriction-mediated longevity: roles of signal-transducing kinases GCN2 and TOR. Biochem J 2013; 449: 1–10.
  CAS PubMed Google Scholar
• Dabo S, Meurs EF . dsRNA-dependent protein kinase PKR and its Role in stress, signaling and HCV infection. Viruses 2012; 4: 2598–2635.
  CAS PubMed PubMed Central Google Scholar
• Boyce M, Bryant KF, Jousse C, Long K, Harding HP, Scheuner D et al. A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress. Science 2005; 307: 935–939.
  CAS PubMed Google Scholar
• Drexler HC . Synergistic apoptosis induction in leukemic cells by the phosphatase inhibitor salubrinal and proteasome inhibitors. PLoS One 2009; 4: e4161.
  PubMed PubMed Central Google Scholar
• Schewe DM, Aguirre-Ghiso JA . Inhibition of eIF2alpha dephosphorylation maximizes bortezomib efficiency and eliminates quiescent multiple myeloma cells surviving proteasome inhibitor therapy. Cancer Res 2009; 69: 1545–1552.
  CAS PubMed PubMed Central Google Scholar
• Zoncu R, Efeyan A, Sabatini DM . mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 2011; 12: 21–35.
  CAS PubMed Google Scholar
• Petroulakis E, Mamane Y, Le Bacquer O, Shahbazian D, Sonenberg N . mTOR signaling: implications for cancer and anticancer therapy. Br J Cancer 2006; 94: 195–199.
  CAS PubMed Google Scholar
• Dowling RJ, Topisirovic I, Alain T, Bidinosti M, Fonseca BD, Petroulakis E et al. mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science 2012; 328: 1172–1176.
  Google Scholar
• Hsieh AC, Costa M, Zollo O, Davis C, Feldman ME, Testa JR et al. Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E. Cancer Cell 2010; 17: 249–261.
  CAS PubMed PubMed Central Google Scholar
• Alain T, Morita M, Fonseca BD, Yanagiya A, Siddiqui N, Bhat M et al. eIF4E/4E-BP ratio predicts the efficacy of mTOR targeted therapies. Cancer Res 2012; 72: 6468–6476.
  CAS PubMed Google Scholar
• Grosso S, Pesce E, Brina D, Beugnet A, Loreni F, Biffo S . Sensitivity of global translation to mTOR inhibition in REN cells depends on the equilibrium between eIF4E and 4E-BP1. PLoS One 2011; 6: e29136.
  CAS PubMed PubMed Central Google Scholar
• Raught B, Peiretti F, Gingras AC, Livingstone M, Shahbazian D, Mayeur GL et al. Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases. EMBO J 2004; 23: 1761–1769.
  CAS PubMed PubMed Central Google Scholar
• Magnuson B, Ekim B, Fingar DC . Regulation and function of ribosomal protein S6 kinase (S6K) within mTOR signaling networks. Biochem J 2012; 441: 1–21.
  CAS PubMed Google Scholar
• Browne GJ, Proud CG . A novel mTOR-regulated phosphorylation site in elongation factor 2 kinase modulates the activity of the kinase and its binding to calmodulin. Mol Cell Biol 2004; 24: 2986–2997.
  CAS PubMed PubMed Central Google Scholar
• Mayer C, Grummt I . Ribosome biogenesis and cell growth: mTOR coordinates transcription by all three classes of nuclear RNA polymerases. Oncogene 2006; 25: 6384–6391.
  CAS PubMed Google Scholar
• Wang X, Beugnet A, Murakami M, Yamanaka S, Proud CG . Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins. Mol Cell Biol 2005; 25: 2558–2572.
  CAS PubMed PubMed Central Google Scholar
• Sanvito F, Piatti S, Villa A, Bossi M, Lucchini G, Marchisio PC et al. The beta4 integrin interactor p27(BBP/eIF6) is an essential nuclear matrix protein involved in 60S ribosomal subunit assembly. J Cell Biol 1999; 144: 823–837.
  CAS PubMed PubMed Central Google Scholar
• Si K, Maitra U . The Saccharomyces cerevisiae homologue of mammalian translation initiation factor 6 does not function as a translation initiation factor. Mol Cell Biol 1999; 19: 1416–1426.
  CAS PubMed PubMed Central Google Scholar
• Gandin V, Miluzio A, Barbieri AM, Beugnet A, Kiyokawa H, Marchisio PC et al. Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation. Nature 2008; 455: 684–688.
  CAS PubMed PubMed Central Google Scholar
• Diggle TA, Moule SK, Avison MB, Flynn A, Foulstone EJ, Proud CG et al. Both rapamycin-sensitive and -insensitive pathways are involved in the phosphorylation of the initiation factor-4E-binding protein (4E-BP1) in response to insulin in rat epididymal fat-cells. Biochem J 1996; 316 (Pt 2): 447–453.
  CAS PubMed PubMed Central Google Scholar
• Di Nicolantonio F, Arena S, Tabernero J, Grosso S, Molinari F, Macarulla T et al. Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus. J Clin Invest 2010; 120: 2858–2866.
  CAS PubMed PubMed Central Google Scholar
• Grosso S, Volta V, Sala LA, Vietri M, Marchisio PC, Ron D et al. PKCbetaII modulates translation independently from mTOR and through RACK1. Biochem J 2008; 415: 77–85.
  CAS PubMed Google Scholar
• Gorrini C, Loreni F, Gandin V, Sala LA, Sonenberg N, Marchisio PC et al. Fibronectin controls cap-dependent translation through beta1 integrin and eukaryotic initiation factors 4 and 2 coordinated pathways. Proc Natl Acad Sci USA 2005; 102: 9200–9205.
  CAS PubMed PubMed Central Google Scholar
• Ueda T, Watanabe-Fukunaga R, Fukuyama H, Nagata S, Fukunaga R . Mnk2 and Mnk1 are essential for constitutive and inducible phosphorylation of eukaryotic initiation factor 4E but not for cell growth or development. Mol Cell Biol 2004; 24: 6539–6549.
  CAS PubMed PubMed Central Google Scholar
• Furic L, Rong L, Larsson O, Koumakpayi IH, Yoshida K, Brueschke A et al. eIF4E phosphorylation promotes tumorigenesis and is associated with prostate cancer progression. Proc Natl Acad Sci USA 2010; 107: 14134–14139.
  CAS PubMed PubMed Central Google Scholar
• Wendel HG, Silva RL, Malina A, Mills JR, Zhu H, Ueda T et al. Dissecting eIF4E action in tumorigenesis. Genes Dev 2007; 21: 3232–3237.
  CAS PubMed PubMed Central Google Scholar
• Parsyan A, Svitkin Y, Shahbazian D, Gkogkas C, Lasko P, Merrick WC et al. mRNA helicases: the tacticians of translational control. Nat Rev Mol Cell Biol 2011; 12: 235–245.
  CAS PubMed Google Scholar
• Brina D, Grosso S, Miluzio A, Biffo S . Translational control by 80S formation and 60S availability: the central role of eIF6, a rate limiting factor in cell cycle progression and tumorigenesis. Cell Cycle 2011; 10: 3441–3446.
  CAS PubMed Google Scholar
• Sanvito F, Vivoli F, Gambini S, Santambrogio G, Catena M, Viale E et al. Expression of a highly conserved protein, p27BBP, during the progression of human colorectal cancer. Cancer Res 2000; 60: 510–516.
  CAS PubMed Google Scholar
• Miluzio A, Beugnet A, Grosso S, Brina D, Mancino M, Campaner S et al. Impairment of cytoplasmic eIF6 activity restricts lymphomagenesis and tumor progression without affecting normal growth. Cancer Cell 2011; 19: 765–775.
  CAS PubMed Google Scholar
• Ceci M, Gaviraghi C, Gorrini C, Sala LA, Offenhauser N, Marchisio PC et al. Release of eIF6 (p27BBP) from the 60S subunit allows 80S ribosome assembly. Nature 2003; 426: 579–584.
  CAS PubMed Google Scholar
• Dephoure N, Zhou C, Villen J, Beausoleil SA, Bakalarski CE, Elledge SJ et al. A quantitative atlas of mitotic phosphorylation. Proc Natl Acad Sci USA 2008; 105: 10762–10767.
  CAS PubMed PubMed Central Google Scholar
• Wong CC, Traynor D, Basse N, Kay RR, Warren AJ . Defective ribosome assembly in Shwachman-Diamond syndrome. Blood 2011; 118: 4305–4312.
  CAS PubMed Google Scholar
• Liu JM, Lipton JM, Mani S . Sixth International Congress on Shwachman-Diamond syndrome: from patients to genes and back. Ann N Y Acad Sci 2011; 1242: 26–39.
  CAS PubMed PubMed Central Google Scholar
• Sharma G, Pallesen J, Das S, Grassucci R, Langlois R, Hampton CM et al. Affinity grid-based cryo-EM of PKC binding to RACK1 on the ribosome. J Struct Biol 2013; 181: 190–194.
  CAS PubMed Google Scholar
• Gibson TJ . RACK1 research—ships passing in the night? FEBS Lett 2012; 586: 2787–2789.
  CAS PubMed Google Scholar
• Ron D, Luo J, Mochly-Rosen D . C2 region-derived peptides inhibit translocation and function of beta protein kinase C in vivo. J Biol Chem 1995; 270: 24180–24187.
  CAS PubMed Google Scholar
• Ruan Y, Sun L, Hao Y, Wang L, Xu J, Zhang W et al. Ribosomal RACK1 promotes chemoresistance and growth in human hepatocellular carcinoma. J Clin Invest 2012; 122: 2554–2566.
  CAS PubMed PubMed Central Google Scholar
• Podar K, Anderson KC . Emerging therapies targeting tumor vasculature in multiple myeloma and other hematologic and solid malignancies. Curr Cancer Drug Targets 2011; 11: 1005–1024.
  CAS PubMed Google Scholar
• Dumstorf CA, Konicek BW, McNulty AM, Parsons SH, Furic L, Sonenberg N et al. Modulation of 4E-BP1 function as a critical determinant of enzastaurin-induced apoptosis. Mol Cancer Ther 2010; 9: 3158–3163.
  CAS PubMed Google Scholar
• Dobrikov M, Dobrikova E, Shveygert M, Gromeier M . Phosphorylation of eukaryotic translation initiation factor 4G1 (eIF4G1) by protein kinase C{alpha} regulates eIF4G1 binding to Mnk1. Mol Cell Biol 2011; 31: 2947–2959.
  CAS PubMed PubMed Central Google Scholar
• Volta V, Beugnet A, Gallo S, Magri L, Brina D, Pesce E et al. RACK1 depletion in a mouse model causes lethality, pigmentation deficits and reduction in protein synthesis efficiency. Cell Mol Life Sci 2013; 70: 1439–1450.
  CAS PubMed Google Scholar
• Ceci M, Welshhans K, Ciotti MT, Brandi R, Parisi C, Paoletti F et al. RACK1 is a ribosome scaffold protein for beta-actin mRNA/ZBP1 complex. PLoS One 2012; 7: e35034.
  CAS PubMed PubMed Central Google Scholar
• Otsuka M, Takata A, Yoshikawa T, Kojima K, Kishikawa T, Shibata C et al. Receptor for activated protein kinase C: requirement for efficient microRNA function and reduced expression in hepatocellular carcinoma. PLoS One 2011; 6: e24359.
  CAS PubMed PubMed Central Google Scholar
• Jannot G, Bajan S, Giguere NJ, Bouasker S, Banville IH, Piquet S et al. The ribosomal protein RACK1 is required for microRNA function in both C. elegans and humans. EMBO Rep 2011; 12: 581–586.
  CAS PubMed PubMed Central Google Scholar
• Ruggero D . The role of Myc-induced protein synthesis in cancer. Cancer Res 2009; 69: 8839–8843.
  CAS PubMed PubMed Central Google Scholar
• van Riggelen J, Yetil A, Felsher DW . MYC as a regulator of ribosome biogenesis and protein synthesis. Nat Rev Cancer 2010; 10: 301–309.
  CAS PubMed Google Scholar
• Devlin JR, Hannan KM, Ng PY, Bywater MJ, Shortt J, Cullinane C et al. AKT signaling is required for ribosomal RNA synthesis and progression of Emu-Myc B-cell lymphoma in vivo. FEBS J (e-pub ahead of print 13 February 2013; doi:10.1111/febs.12135).
  CAS Google Scholar
• Zhang L, Smit-McBride Z, Pan X, Rheinhardt J, Hershey JW . An oncogenic role for the phosphorylated h-subunit of human translation initiation factor eIF3. J Biol Chem 2008; 283: 24047–24060.
  CAS PubMed PubMed Central Google Scholar
• Wen F, Zhou R, Shen A, Choi A, Uribe D, Shi J . The tumor suppressive role of eIF3f and its function in translation inhibition and rRNA degradation. PLoS One 2011; 7: e34194.
  Google Scholar
• Daxinger L, Oey H, Apedaile A, Sutton J, Ashe A, Whitelaw E . A forward genetic screen identifies eukaryotic translation initiation factor 3, subunit H (eIF3h), as an enhancer of variegation in the mouse. G3 2012; 2: 1393–1396.
  CAS PubMed PubMed Central Google Scholar
• Badura M, Braunstein S, Zavadil J, Schneider RJ . DNA damage and eIF4G1 in breast cancer cells reprogram translation for survival and DNA repair mRNAs. Proc Natl Acad Sci USA 2012; 109: 18767–18772.
  CAS PubMed PubMed Central Google Scholar
• Scuoppo C, Miething C, Lindqvist L, Reyes J, Ruse C, Appelmann I et al. A tumor suppressor network relying on the polyamine-hypusine axis. Nature 2012; 487: 244–248.
  CAS PubMed PubMed Central Google Scholar
• Doerfel LK, Wohlgemuth I, Kothe C, Peske F, Urlaub H, Rodnina MV . EF-P is essential for rapid synthesis of proteins containing consecutive proline residues. Science 2013; 339: 85–88.
  CAS PubMed Google Scholar
• Saini P, Eyler DE, Green R, Dever TE . Hypusine-containing protein eIF5A promotes translation elongation. Nature 2009; 459: 118–121.
  CAS PubMed PubMed Central Google Scholar
• Luft F . The rise of a ribosomopathy and increased cancer risk. J Mol Med 2010; 88: 1–3.
  PubMed Google Scholar
• Heiss NS, Knight SW, Vulliamy TJ, Klauck SM, Wiemann S, Mason PJ et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat Genet 1998; 19: 32–38.
  CAS PubMed Google Scholar
• Ruggero D, Grisendi S, Piazza F, Rego E, Mari F, Rao PH et al. Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 2003; 299: 259–262.
  CAS PubMed Google Scholar
• Lafontaine DL, Bousquet-Antonelli C, Henry Y, Caizergues-Ferrer M, Tollervey D . The box H+ACA snoRNAs carry Cbf5p, the putative rRNA pseudouridine synthase. Genes Dev 1998; 12: 527–537.
  CAS PubMed PubMed Central Google Scholar
• Montanaro L, Calienni M, Bertoni S, Rocchi L, Sansone P, Storci G et al. Novel dyskerin-mediated mechanism of p53 inactivation through defective mRNA translation. Cancer Res 2010; 70: 4767–4777.
  CAS PubMed Google Scholar
• Basu A, Das P, Chaudhuri S, Bevilacqua E, Andrews J, Barik S et al. Requirement of rRNA methylation for 80S ribosome assembly on a cohort of cellular internal ribosome entry sites. Mol Cell Biol 2011; 31: 4482–4499.
  CAS PubMed PubMed Central Google Scholar
• Belin S, Beghin A, Solano-Gonzalez E, Bezin L, Brunet-Manquat S, Textoris J et al. Dysregulation of ribosome biogenesis and translational capacity is associated with tumor progression of human breast cancer cells. PLoS One 2009; 4: e7147.
  PubMed PubMed Central Google Scholar
• Kondrashov N, Pusic A, Stumpf CR, Shimizu K, Hsieh AC, Xue S et al. Ribosome-mediated specificity in Hox mRNA translation and vertebrate tissue patterning. Cell 2011; 145: 383–397.
  CAS PubMed PubMed Central Google Scholar
• Landry DM, Hertz MI, Thompson SR . RPS25 is essential for translation initiation by the Dicistroviridae and hepatitis C viral IRESs. Genes Dev 2009; 23: 2753–2764.
  CAS PubMed PubMed Central Google Scholar
• Ellis SR, Lipton JM . Diamond Blackfan anemia: a disorder of red blood cell development. Curr Top Dev Biol 2008; 82: 217–241.
  CAS PubMed Google Scholar
• Vlachos A, Rosenberg PS, Atsidaftos E, Alter BP, Lipton JM . Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. Blood 2012; 119: 3815–3819.
  CAS PubMed PubMed Central Google Scholar
• Gazda HT, Sheen MR, Vlachos A, Choesmel V, O'Donohue MF, Schneider H et al. Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am J Hum Genet 2008; 83: 769–780.
  CAS PubMed PubMed Central Google Scholar
• Boria I, Quarello P, Avondo F, Garelli E, Aspesi A, Carando A et al. A new database for ribosomal protein genes which are mutated in Diamond-Blackfan Anemia. Hum Mutat 2008; 29: E263–E270.
  PubMed Google Scholar
• Horos R, Ijspeert H, Pospisilova D, Sendtner R, Andrieu-Soler C, Taskesen E et al. Ribosomal deficiencies in Diamond-Blackfan anemia impair translation of transcripts essential for differentiation of murine and human erythroblasts. Blood 2012; 119: 262–272.
  CAS PubMed Google Scholar
• Anderson SJ, Lauritsen JP, Hartman MG, Foushee AM, Lefebvre JM, Shinton SA et al. Ablation of ribosomal protein L22 selectively impairs alphabeta T cell development by activation of a p53-dependent checkpoint. Immunity 2007; 26: 759–772.
  CAS PubMed Google Scholar
• Kirn-Safran CB, Oristian DS, Focht RJ, Parker SG, Vivian JL, Carson DD . Global growth deficiencies in mice lacking the ribosomal protein HIP/RPL29. Dev Dyn 2007; 236: 447–460.
  CAS PubMed Google Scholar
• Lam YW, Lamond AI, Mann M, Andersen JS . Analysis of nucleolar protein dynamics reveals the nuclear degradation of ribosomal proteins. Curr Biol 2007; 17: 749–760.
  CAS PubMed PubMed Central Google Scholar
• Robledo S, Idol RA, Crimmins DL, Ladenson JH, Mason PJ, Bessler M . The role of human ribosomal proteins in the maturation of rRNA and ribosome production. RNA 2008; 14: 1918–1929.
  CAS PubMed PubMed Central Google Scholar
• Choesmel V, Bacqueville D, Rouquette J, Noaillac-Depeyre J, Fribourg S, Cretien A et al. Impaired ribosome biogenesis in Diamond-Blackfan anemia. Blood 2007; 109: 1275–1283.
  CAS PubMed PubMed Central Google Scholar
• Flygare J, Aspesi A, Bailey JC, Miyake K, Caffrey JM, Karlsson S et al. Human RPS19, the gene mutated in Diamond-Blackfan anemia, encodes a ribosomal protein required for the maturation of 40S ribosomal subunits. Blood 2007; 109: 980–986.
  CAS PubMed PubMed Central Google Scholar
• Idol RA, Robledo S, Du HY, Crimmins DL, Wilson DB, Ladenson JH et al. Cells depleted for RPS19, a protein associated with Diamond Blackfan Anemia, show defects in 18S ribosomal RNA synthesis and small ribosomal subunit production. Blood Cells Mol Dis 2007; 39: 35–43.
  CAS PubMed Google Scholar
• Angelini M, Cannata S, Mercaldo V, Gibello L, Santoro C, Dianzani I et al. Missense mutations associated with Diamond-Blackfan anemia affect the assembly of ribosomal protein S19 into the ribosome. Hum Mol Genet 2007; 16: 1720–1727.
  CAS PubMed Google Scholar
• Lodish HF . Alpha and beta globin messenger ribonucleic acid. Different amounts and rates of initiation of translation. J Biol Chem 1971; 246: 7131–7138.
  CAS PubMed Google Scholar
• Walden WE, Godefroy-Colburn T, Thach RE . The role of mRNA competition in regulating translation. I. Demonstration of competition in vivo. J Biol Chem 1981; 256: 11739–11746.
  CAS PubMed Google Scholar
• Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher A et al. The translational landscape of mTOR signaling steers cancer initiation and metastasis. Nature 2012; 485: 55–61.
  CAS PubMed PubMed Central Google Scholar
• Walden WE, Thach RE . Translational control of gene expression in a normal fibroblast. Characterization of a subclass of mRNAs with unusual kinetic properties. Biochemistry 1986; 25: 2033–2041.
  CAS PubMed Google Scholar
• Zinzalla V, Stracka D, Oppliger W, Hall MN . Activation of mTORC2 by association with the ribosome. Cell 2011; 144: 757–768.
  CAS PubMed Google Scholar
• Oh WJ, Wu CC, Kim SJ, Facchinetti V, Julien LA, Finlan M et al. mTORC2 can associate with ribosomes to promote cotranslational phosphorylation and stability of nascent Akt polypeptide. EMBO J 2010; 29: 3939–3951.
  CAS PubMed PubMed Central Google Scholar
• Payne EM, Virgilio M, Narla A, Sun H, Levine M, Paw BH et al. L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway. Blood 2012; 120: 2214–2224.
  CAS PubMed PubMed Central Google Scholar
• Iadevaia V, Caldarola S, Biondini L, Gismondi A, Karlsson S, Dianzani I et al. PIM1 kinase is destabilized by ribosomal stress causing inhibition of cell cycle progression. Oncogene 2010; 29: 5490–5499.
  CAS PubMed Google Scholar
• Danilova N, Sakamoto KM, Lin S . Ribosomal protein S19 deficiency in zebrafish leads to developmental abnormalities and defective erythropoiesis through activation of p53 protein family. Blood 2008; 112: 5228–5237.
  CAS PubMed Google Scholar
• Panic L, Montagne J, Cokaric M, Volarevic S . S6-haploinsufficiency activates the p53 tumor suppressor. Cell Cycle 2007; 6: 20–24.
  CAS PubMed Google Scholar
• Pestov DG, Strezoska Z, Lau LF . Evidence of p53-dependent cross-talk between ribosome biogenesis and the cell cycle: effects of nucleolar protein Bop1 on G(1)/S transition. Mol Cell Biol 2001; 21: 4246–4255.
  CAS PubMed PubMed Central Google Scholar
• Rubbi CP, Milner J . Disruption of the nucleolus mediates stabilization of p53 in response to DNA damage and other stresses. EMBO J 2003; 22: 6068–6077.
  CAS PubMed PubMed Central Google Scholar
• Fumagalli S, Di Cara A, Neb-Gulati A, Natt F, Schwemberger S, Hall J et al. Absence of nucleolar disruption after impairment of 40S ribosome biogenesis reveals an rpL11-translation-dependent mechanism of p53 induction. Nat Cell Biol 2009; 11: 501–508.
  CAS PubMed PubMed Central Google Scholar
• McGowan KA, Li JZ, Park CY, Beaudry V, Tabor HK, Sabnis AJ et al. Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects. Nat Genet 2008; 40: 963–970.
  CAS PubMed PubMed Central Google Scholar
• Fumagalli S, Ivanenkov VV, Teng T, Thomas G . Suprainduction of p53 by disruption of 40S and 60S ribosome biogenesis leads to the activation of a novel G2/M checkpoint. Genes Dev 2012; 26: 1028–1040.
  CAS PubMed PubMed Central Google Scholar
• Donati G, Montanaro L, Derenzini M . Ribosome biogenesis and control of cell proliferation: p53 is not alone. Cancer Res 2012; 72: 1602–1607.
  CAS PubMed Google Scholar
• Torihara H, Uechi T, Chakraborty A, Shinya M, Sakai N, Kenmochi N . Erythropoiesis failure due to RPS19 deficiency is independent of an activated Tp53 response in a zebrafish model of Diamond-Blackfan anaemia. Br J Haematol 2011; 152: 648–654.
  CAS PubMed Google Scholar
• Lindstrom MS, Nister M . Silencing of ribosomal protein S9 elicits a multitude of cellular responses inhibiting the growth of cancer cells subsequent to p53 activation. PLoS One 2010; 5: e9578.
  PubMed PubMed Central Google Scholar
• Amsterdam A, Sadler KC, Lai K, Farrington S, Bronson RT, Lees JA et al. Many ribosomal protein genes are cancer genes in zebrafish. PLoS Biol 2004; 2: E139.
  PubMed PubMed Central Google Scholar
• MacInnes AW, Amsterdam A, Whittaker CA, Hopkins N, Lees JA . Loss of p53 synthesis in zebrafish tumors with ribosomal protein gene mutations. Proc Natl Acad Sci USA 2008; 105: 10408–10413.
  CAS PubMed PubMed Central Google Scholar
• Ebert BL, Pretz J, Bosco J, Chang CY, Tamayo P, Galili N et al. Identification of RPS14 as a 5q- syndrome gene by RNA interference screen. Nature 2008; 451: 335–339.
  CAS PubMed PubMed Central Google Scholar
• Barlow JL, Drynan LF, Hewett DR, Holmes LR, Lorenzo-Abalde S, Lane AL et al. A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome. Nat Med 2010; 16: 59–66.
  CAS PubMed Google Scholar
• Jadersten M, Saft L, Smith A, Kulasekararaj A, Pomplun S, Gohring G et al. TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progression. J Clin Oncol 2011; 29: 1971–1979.
  PubMed Google Scholar
• Da Costa L, Moniz H, Simansour M, Tchernia G, Mohandas N, Leblanc T . Diamond-Blackfan anemia, ribosome and erythropoiesis. Transfus Clin Biol 2010; 17: 112–119.
  CAS PubMed Google Scholar
• Alter BP, Giri N, Savage SA, Rosenberg PS . Cancer in dyskeratosis congenita. Blood 2009; 113: 6549–6557.
  CAS PubMed PubMed Central Google Scholar
• Boocock GR, Morrison JA, Popovic M, Richards N, Ellis L, Durie PR et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet 2003; 33: 97–101.
  CAS PubMed Google Scholar
• Burroughs L, Woolfrey A, Shimamura A . Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment. Hem Oncol Clin N Am 2009; 23: 233–248.
  Google Scholar
• Ganapathi KA, Shimamura A . Ribosomal dysfunction and inherited marrow failure. Br J Haematol 2008; 141: 376–387.
  CAS PubMed Google Scholar
• Ridanpaa M, van Eenennaam H, Pelin K, Chadwick R, Johnson C, Yuan B et al. Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell 2001; 104: 195–203.
  CAS PubMed Google Scholar
• Taskinen M, Ranki A, Pukkala E, Jeskanen L, Kaitila I, Makitie O . Extended follow-up of the Finnish cartilage-hair hypoplasia cohort confirms high incidence of non-Hodgkin lymphoma and basal cell carcinoma. Am J Med Genet 2008; 146A: 2370–2375.
  PubMed Google Scholar
• Valdez BC, Henning D, So RB, Dixon J, Dixon MJ . The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor. Proc Natl Acad Sci USA 2004; 101: 10709–10714.
  CAS PubMed PubMed Central Google Scholar